Answers are grounded in this paper and cite their sources.
Short communication emphasizes advancements in biological control efficacy and safety in New Zealand, indicating a crucial shift in practices.
This short communication outlines the imperative for advances in classical biological control, often based on molecular technologies, to accentuate the efficacy of impact while being cognisant of the need for biological control safety.
No takes yet. Share an insight, caveat, or question.
Goldson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: